ZA200303276B - Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug. - Google Patents

Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug.

Info

Publication number
ZA200303276B
ZA200303276B ZA200303276A ZA200303276A ZA200303276B ZA 200303276 B ZA200303276 B ZA 200303276B ZA 200303276 A ZA200303276 A ZA 200303276A ZA 200303276 A ZA200303276 A ZA 200303276A ZA 200303276 B ZA200303276 B ZA 200303276B
Authority
ZA
South Africa
Prior art keywords
anticancer drug
pharmaceutical form
stable pharmaceutical
production
stable
Prior art date
Application number
ZA200303276A
Other languages
English (en)
Inventor
Stanislaw Janicki
Malgorzata Sznitowska
Wladyslaw Karas
Zdzislaw Mroczek
Andrzej Tyrala
Iwona Czarnecka
Original Assignee
Warszawskie Zaklady Farma
Akad Medyczna
Inst Chemii Organicznej Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawskie Zaklady Farma, Akad Medyczna, Inst Chemii Organicznej Pan filed Critical Warszawskie Zaklady Farma
Publication of ZA200303276B publication Critical patent/ZA200303276B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200303276A 2000-10-31 2003-04-29 Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug. ZA200303276B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL343615A PL203300B1 (pl) 2000-10-31 2000-10-31 Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego

Publications (1)

Publication Number Publication Date
ZA200303276B true ZA200303276B (en) 2004-04-21

Family

ID=20077651

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200303276A ZA200303276B (en) 2000-10-31 2003-04-29 Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug.

Country Status (15)

Country Link
EP (1) EP1363892B1 (pl)
AU (1) AU2002212863A1 (pl)
BG (1) BG65985B1 (pl)
CZ (1) CZ300836B6 (pl)
DE (1) DE60122384T2 (pl)
HK (1) HK1060733A1 (pl)
HU (1) HUP0303089A3 (pl)
LT (1) LT5069B (pl)
PL (1) PL203300B1 (pl)
RU (1) RU2236227C1 (pl)
SI (1) SI21138B (pl)
SK (1) SK287850B6 (pl)
UA (1) UA75620C2 (pl)
WO (1) WO2002036582A1 (pl)
ZA (1) ZA200303276B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050044621A (ko) * 2001-11-30 2005-05-12 브리스톨-마이어스 스큅 컴퍼니 파클리탁셀 용매화물
EP1694660B1 (en) 2003-12-12 2009-04-08 Quiral Quimica Do Brasil Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
AR054215A1 (es) * 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
CN110437179A (zh) * 2019-08-22 2019-11-12 江苏红豆杉药业有限公司 一种紫杉醇单晶晶体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates

Also Published As

Publication number Publication date
HUP0303089A2 (hu) 2003-12-29
CZ20031421A3 (cs) 2004-06-16
SK287850B6 (sk) 2012-01-04
SK6292003A3 (en) 2004-08-03
EP1363892A1 (en) 2003-11-26
CZ300836B6 (cs) 2009-08-19
HK1060733A1 (en) 2004-08-20
SI21138A (sl) 2003-08-31
EP1363892B1 (en) 2006-08-16
LT5069B (lt) 2003-11-25
BG65985B1 (bg) 2010-08-31
RU2236227C1 (ru) 2004-09-20
UA75620C2 (en) 2006-05-15
AU2002212863A1 (en) 2002-05-15
PL343615A1 (en) 2002-05-06
LT2003031A (en) 2003-09-25
PL203300B1 (pl) 2009-09-30
BG107764A (bg) 2004-07-30
DE60122384T2 (de) 2007-08-16
HUP0303089A3 (en) 2005-02-28
SI21138B (sl) 2006-10-31
WO2002036582A1 (en) 2002-05-10
DE60122384D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
MXPA02003596A (es) Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion.
AU2682401A (en) Flavonoid drug and dosage form, its production and use
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
HUP0105478A2 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
IL149186A0 (en) Pharmaceutical compositions providing enhanced drug concentrations
HUP0000748A2 (en) 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0302257A3 (en) 4-hydrazino-5-hydroxy-5-pyrazol derivatives, pharmaceutical compositions containing them, process for producing them and their intermediates
IL160797A0 (en) ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17beta-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
AU6271401A (en) Drug administering system and administering method
IL154012A0 (en) Hydrogel-driven drug dosage form
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
AU2001278849A1 (en) Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives
SG116507A1 (en) Pharmaceutical dosage form and method of making.
HUP0302050A3 (en) Pharmaceutical form of administration for peptides, method for its production and use
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
HUP0400549A3 (en) Novel imidazole derivatives, production method thereof and pharmaceutical compositions containing them
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
NO20026212D0 (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
AP2003002927A0 (en) Pharmaceutical formulation having a masked taste and method for the production thereof.
HUP0105479A3 (en) Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
ZA200303276B (en) Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug.
PL359208A1 (pl) Nowe pochodne chinazoliny, sposób wytwarzania nowych pochodnych chinazoliny i kompozycje farmaceutyczne
HUP0003861A3 (en) Quinolin-4-yl derivatives, process for producing them and pharmaceutical compositions containing them
HUP0200928A2 (hu) Pirido-tieno-diazepinek, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
HUP0203310A3 (en) Stable pharmaceutical compositions comprising benzimidazol and method for the production thereof